October 18, 2021

Monoclonal Drug Therapy to Treat COVID-19 Available at Mountainside Medical Center

Mountainside Medical Center is offering monoclonal antibody treatment [Regen-Cov] to patients with confirmed COVID-19. The use of monoclonal antibody treatment has been shown to reduce the risk of hospitalization and death.

Those who qualify for monoclonal antibody treatment include:

· Individuals, 12 years and older weighing at least 88 pounds, with confirmed COVID-19 who are at risk of progressing to severe COVID-19 (including those who are 65 years of age or older, those with certain chronic medical conditions and those who are unvaccinated).

· Individuals who have been exposed to COVID-19 positive patients and are at risk of developing severe disease or hospitalization.

Treatment is available 24 hours a day, 7 days a week.

For more information about monoclonal drug therapy to treat COVID-19 and COVID-19 vaccination availability, please visit mountainsidehosp.com/coronavirus.

If you have tested positive for COVID-19 and are interested in monoclonal antibody treatment, please speak to your doctor or make a virtual appointment with a Mountainside Medical Group provider. Visit mountainsidehosp.com/virtualcare to schedule your appointment or call 866-999-5162.



Share this: